Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

19. Februar 2022 07:18 ET | Quelle: The Rosen Law Firm PA

ROSEN, A RESPECTED LAW FIRM, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors With Losses to Secure Counsel Before Important February 28 Deadline in Securities Class Action – INSD, MZKR

NEW YORK, Feb. 19, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (OTC: INSD,...
11. Februar 2022 15:18 ET | Quelle: The Rosen Law Firm PA

ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – INSD, MZKR

NEW YORK, Feb. 11, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (OTC: INSD,...
22. Januar 2022 12:04 ET | Quelle: The Rosen Law Firm PA

ROSEN, A LEADING LAW FIRM, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important February 28 Deadline in Securities Class Action – INSD, MZKR

NEW YORK, Jan. 22, 2022 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., January 22, 2022. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Instadose Pharma Corp....
16. Januar 2022 11:45 ET | Quelle: The Rosen Law Firm PA

ROSEN, A TOP RANKED LAW FIRM, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors With Losses to Secure Counsel Before Important February 28 Deadline in Securities Class Action – INSD, MZKR

NEW YORK, Jan. 16, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (OTCMKTS:...